首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Advanced therapeutics

缩写:

ISSN:N/A

e-ISSN:2366-3987

IF/分区:3.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引147条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Derek W Nelson,Jessica L Funnell,Conrad H Cheung et al. Derek W Nelson et al.
Multiple therapies have been studied to ameliorate the neuroinhibitory cues present after traumatic injury to the central nervous system. Two previous in vitro studies have demonstrated the efficacy of the FDA-approved cardiovascular therap...
Megan N Dang,Sejal Suri,Kejian Li et al. Megan N Dang et al.
The paucity of targeted therapies for triple-negative breast cancer (TNBC) causes patients with this aggressive disease to suffer a poor clinical prognosis. A promising target for therapeutic intervention is the Wnt signaling pathway, which...
Dayeon Kang,Damayanti Bagchi,Irene A Chen Dayeon Kang
Antimicrobial resistance remains a critical global health concern, necessitating the investigation of alternative therapeutic approaches. With the diminished efficacy of conventional small molecule drugs due to the emergence of highly resil...
Faraz Jivan,Daniel L Alge Faraz Jivan
Protein conjugation to biomaterial scaffolds is a powerful approach for tissue engineering. However, typical chemical conjugation methods lack site-selectivity and can negatively impact protein bioactivity. To overcome this problem, a site-...
Danielle E Large,Jonathan R Soucy,Jacob Hebert et al. Danielle E Large et al.
Receptor-mediated drug delivery presents an opportunity to enhance therapeutic efficiency by accumulating drug within the tissue of interest and reducing undesired, off-target effects. In cancer, receptor overexpression is a platform for bi...
Bahaa Mustafa,John Fetse,Sashi Kandel et al. Bahaa Mustafa et al.
Cancer immunotherapy targeting adaptive immune cells has been attracting considerable interest due to its great success in treating multiple cancers. Recently, there is also increasing interest in agents that can stimulate innate immune cel...
Aria W Tarudji,Connor C Gee,Hunter A Miller et al. Aria W Tarudji et al.
Following a traumatic brain injury (TBI), excess reactive oxygen species (ROS) and lipid peroxidation products (LPOx) are generated and lead to secondary injury beyond the primary insult. A major limitation of current treatments is poor tar...
Rui Kuai,Priti B Singh,Xiaoqi Sun et al. Rui Kuai et al.
Potent anti-tumor T cell response and efficient intratumoral T cell infiltration are the major challenges for therapeutic cancer vaccines. To address these issues, a nano-vaccine system has been designed to promote anti-tumor T cell respons...
Yurui Wang,Yiran Song,Yazhi He et al. Yurui Wang et al.
The immune system plays a crucial role in recognizing and eliminating pathogenic substances and malignant cells in the body. For cancer treatment, immunotherapy is becoming the standard treatment for many types of cancer and is often combin...
Abdul-Rahman Azizogli,Michael R Vitti,Richa Mishra et al. Abdul-Rahman Azizogli et al.
Diabetes Mellitus Type 2 (T2D) is an emerging health burden in the USand worldwide, impacting approximately 15% of Americans. Current front-line therapeutics for T2D patients include sulfonylureas that act to reduce A1C and/or fasting blood...